Clinical Trial Update: The isCGM Use and Hypoglycemic Episodes and Fear of Hypoglycemia in Newly Diagnosed Type 1 Diabetes [NA]

View source ↗

Summary

A terminated clinical trial evaluating the use of isCGM in newly diagnosed type 1 diabetes and its relation to hypoglycemic episodes and fear of hypoglycemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• isCGM

Snippet

Sponsor: Jagiellonian University | Conditions: Diabetes Mellitus, Type 1 | NA | Status: TERMINATED